Thiouracil, propylthiouracil, benzylthiouracil

Congenital hydronephrosis

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S8484
R27835		 Yoshihara (Controls exposed to MMI), 2021 Hydronephrosis 1st trimester retrospective cohort exposed to other treatment, sick excluded Adjustment: No 0.46 [0.02;8.62] C
excluded (control group) 		5/541   0/23 5 541
ref
S8481
R27769		 Yoshihara (Controls unexposed, sick), 2021 Hydronephrosis 1st trimester retrospective cohort unexposed, sick Adjustment: No 2.21 [0.43;11.42] C 5/541   2/475 7 541
ref
S3355
R6076		 Yoshihara (control exposed to MMI), 2012 Hydronephrosis 1st trimester retrospective cohort exposed to other treatment, sick excluded Adjustment: No 1.76 [0.16;19.44] C
excluded (control group) 		2/1,399   1/1,231 3 1,399
ref
S3354
R6033		 Yoshihara (control unexposed, sick), 2012 Hydronephrosis 1st trimester retrospective cohort unexposed, sick Adjustment: No 6.82 [0.33;142.23] C 2/1,399   0/1,906 2 1,399
ref
Total 2 studies 2.85 [0.67;12.10] 9 1,940
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Yoshihara (Controls unexposed, sick), 2021Yoshihara, 2021 1 2.21[0.43; 11.42]754177%ROB confusion: criticalROB selection: moderateROB classification: unclearROB missing: unclearROB mesure: criticalROB reporting: moderate Yoshihara (control unexposed, sick), 2012Yoshihara, 2012 2 6.82[0.33; 142.23]21,39923%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: lowROB mesure: criticalROB reporting: moderate Total (2 studies) I2 = 0% 2.85[0.67; 12.10]91,9400.920.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, sick; 2: control unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.85[0.67; 12.10]91,9400%NAYoshihara (Controls unexposed, sick), 2021 Yoshihara (control unexposed, sick), 2012 2 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 2.85[0.67; 12.10]91,9400%NAYoshihara (Controls unexposed, sick), 2021 Yoshihara (control unexposed, sick), 2012 2 Tags Adjustment   - No  - No 2.85[0.67; 12.10]91,9400%NAYoshihara (Controls unexposed, sick), 2021 Yoshihara (control unexposed, sick), 2012 2 All studiesAll studies 2.85[0.67; 12.10]91,9400%NAYoshihara (Controls unexposed, sick), 2021 Yoshihara (control unexposed, sick), 2012 20.520.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 3355, 8484

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed, sick controlsunexposed, sick controls 2.85[0.67; 12.10]91,9400%NAYoshihara (Controls unexposed, sick), 2021 Yoshihara (control unexposed, sick), 2012 2 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.03[0.16; 6.58]81,9400%NAYoshihara (Controls exposed to MMI), 2021 Yoshihara (control exposed to MMI), 2012 20.510.01.0